Xylona Bibal, MD
Internal Medicine · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 15 years
- Graduated 2011
Offices
2 locations · Dignity Health · Mercy Doctors Medical Group, Inc
Hospitals listed: UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bibal’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A134695 · Current
Licensed to practise in California · since 2015 · expires 2028-03-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$16,156
Medicare paid this office $16,156 for 86 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 51 | $5,401 | $96 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 20 | $3,087 | $154 |
| Advance care planning, first 30 minutes | 18 | $1,681 | $93 |
| Short return visit (20+ min) | 15 | $1,221 | $76 |
| Short return visit (20+ min) | 15 | $1,115 | $53 |
See all 6 services
| Return visit (30+ min) | 51 | $5,401 | $96 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 20 | $3,087 | $154 |
| Advance care planning, first 30 minutes | 18 | $1,681 | $93 |
| Short return visit (20+ min) | 15 | $1,221 | $76 |
| Short return visit (20+ min) | 15 | $1,115 | $53 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 38 | $585 | $13 |
Who their Medicare patients are
86 Original Medicare patients in 2024. Average age 75 · Women 66% · Also on Medicaid 22% · Health risk score 1.07. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 34% · Depression 20% · Chronic kidney disease 19% · Cancer 19% · Coronary heart disease 16% · Atrial fibrillation 13%.
The office billed $41,495, Medicare allowed $21,155 and paid $16,156; for 225 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 86 | 225 | 75 | 1.07 | $41,495 | $16,156 |
| 2023 | 160 | 463 | 77 | 1.00 | $99,166 | $42,979 |
| 2022 | 204 | 440 | 75 | 1.46 | $98,622 | $38,631 |
| 2021 | 306 | 723 | 75 | 1.43 | $154,616 | $57,914 |
| 2020 | 382 | 831 | 73 | 1.45 | $181,952 | $57,837 |
| 2019 | 524 | 1,316 | 72 | 1.24 | $286,809 | $91,327 |
| 2018 | 433 | 1,069 | 71 | 1.42 | $228,533 | $78,128 |
| 2017 | 178 | 403 | 73 | 1.37 | $84,715 | $33,060 |
| 2016 | 116 | 212 | 76 | 1.34 | $43,150 | $17,043 |
| 2015 | 36 | 64 | 75 | 1.43 | $14,030 | $5,560 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 109 | $19,066 | $112 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 44 | $6,729 | $153 |
| Advance care planning, first 30 minutes | 41 | $3,862 | $94 |
| Short return visit (20+ min) | 37 | $3,017 | $74 |
| Long return visit (40+ min) | 12 | $2,174 | $167 |
| Influenza vaccine split virus, preservative free | 20 | $1,439 | $72 |
| Short return visit (20+ min) | 17 | $1,006 | $48 |
| Administration of influenza virus vaccine | 21 | $762 | $36 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $756 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 31 | $486 | $14 |
2022: 10 services
| Return visit (30+ min) | 97 | $16,260 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 28 | $4,328 | $155 |
| Short return visit (20+ min) | 51 | $3,310 | $53 |
| Return visit (30+ min) | 31 | $2,903 | $83 |
| Advance care planning, first 30 minutes | 30 | $2,838 | $95 |
| Short return visit (20+ min) | 25 | $2,039 | $78 |
| Influenza vaccine split virus, preservative free | 13 | $891 | $69 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $813 | $48 |
| Administration of influenza virus vaccine | 15 | $541 | $36 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $258 | $13 |
2021: 14 services
| Return visit (30+ min) | 104 | $19,637 | $107 |
| Short return visit (20+ min) | 112 | $8,727 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 32 | $5,054 | $158 |
| Advance care planning, first 30 minutes | 36 | $3,490 | $94 |
| Return visit (30+ min) | 34 | $3,238 | $90 |
| Telephone medical discussion with physician, 11-20 minutes | 37 | $2,164 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $2,047 | $93 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $1,733 | $67 |
| Short return visit (20+ min) | 21 | $1,660 | $69 |
| Influenza vaccine split virus, preservative free | 21 | $1,370 | $65 |
| New patient visit (45+ min) | 13 | $1,345 | $103 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 11 | $731 | $66 |
| Administration of influenza virus vaccine | 32 | $675 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 23 | $331 | $14 |
2020: 13 services
| Return visit (30+ min) | 110 | $19,204 | $93 |
| Short return visit (20+ min) | 137 | $5,885 | $32 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 30 | $4,162 | $139 |
| Return visit (30+ min) | 62 | $3,469 | $46 |
| Advance care planning, first 30 minutes | 31 | $3,036 | $98 |
| New patient visit (45+ min) | 20 | $2,989 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,831 | $94 |
| Telephone medical discussion with physician, 11-20 minutes | 49 | $2,601 | $44 |
| Telephone medical discussion with physician, 21-30 minutes | 35 | $2,442 | $70 |
| Short return visit (20+ min) | 31 | $2,230 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,172 | $65 |
| Administration of influenza virus vaccine | 13 | $267 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $265 | $17 |
2019: 13 services
| Short return visit (20+ min) | 297 | $21,897 | $42 |
| Return visit (30+ min) | 98 | $18,617 | $93 |
| Return visit (30+ min) | 166 | $15,046 | $66 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 43 | $5,893 | $137 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 23 | $4,598 | $200 |
| Advance care planning, first 30 minutes | 46 | $4,213 | $92 |
| New patient visit (45+ min) | 30 | $3,825 | $128 |
| Long return visit (40+ min) | 23 | $3,287 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,288 | $64 |
| Influenza vaccine split virus, preservative free | 14 | $818 | $55 |
| Short return visit (20+ min) | 12 | $609 | $51 |
| Administration of influenza virus vaccine | 27 | $565 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $276 | $16 |
2018: 12 services
| Short return visit (20+ min) | 270 | $18,208 | $45 |
| Return visit (30+ min) | 79 | $16,943 | $98 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 49 | $7,160 | $146 |
| Return visit (30+ min) | 84 | $6,473 | $69 |
| Advance care planning, first 30 minutes | 49 | $5,021 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $4,896 | $68 |
| Long return visit (40+ min) | 19 | $3,089 | $134 |
| New patient visit (45+ min) | 13 | $1,636 | $126 |
| Short return visit (20+ min) | 21 | $1,608 | $67 |
| Influenza vaccine split virus, preservative free | 11 | $575 | $52 |
| Administration of influenza virus vaccine | 17 | $430 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $294 | $17 |
2017: 8 services
| Return visit (30+ min) | 67 | $10,061 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $2,973 | $65 |
| Short return visit (20+ min) | 41 | $2,706 | $56 |
| Short return visit (20+ min) | 43 | $2,094 | $46 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,078 | $139 |
| Advance care planning, first 30 minutes | 18 | $1,592 | $88 |
| Return visit (30+ min) | 11 | $844 | $70 |
| Administration of influenza virus vaccine | 11 | $356 | $32 |
2016: 3 services
| Return visit (30+ min) | 38 | $4,738 | $99 |
| Short return visit (20+ min) | 55 | $4,465 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 15 | $251 | $17 |
2015: 1 service
| Short return visit (20+ min) | 16 | $1,116 | $66 |
Medicaid work
$1,030 in 2021
Medicaid paid $1,030 for 30 billed services this clinician did in 2021, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 30 | $1,030 |
| 2021 | 30 | 1 | 15 | $1,030 |
| 2020 | 122 | 2 | 59 | $2,888 |
| 2019 | 311 | 2 | 38 | $10,463 |
| 2018 | 241 | 2 | 36 | $7,600 |
See the largest Medicaid services in earlier years
2020
| Short return visit (20+ min) | 100 | $2,160 |
| Return visit (30+ min) | 22 | $728 |
2019
| Short return visit (20+ min) | 269 | $8,322 |
| Return visit (30+ min) | 42 | $2,141 |
2018
| Short return visit (20+ min) | 229 | $7,012 |
| Return visit (30+ min) | 12 | $588 |
Drugs they prescribed that Part D paid
$251,709
Pharmacies billed $251,709 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (28 of 2,491) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
2,182 generic and fewer than 11 brand-name prescriptions · $251,709 in drug cost · 32 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 15 | $25,165 | $1,678 |
| Jardiance | 11 | $18,305 | $1,664 |
| Ozempic | 14 | $15,793 | $1,128 |
| Farxiga | 12 | $14,251 | $1,188 |
| Xarelto | 15 | $12,561 | $837 |
See all 47 drugs
| Eliquis | 15 | $25,165 | $1,678 |
| Jardiance | 11 | $18,305 | $1,664 |
| Ozempic | 14 | $15,793 | $1,128 |
| Farxiga | 12 | $14,251 | $1,188 |
| Xarelto | 15 | $12,561 | $837 |
| Breo Ellipta | 12 | $7,546 | $629 |
| Spiriva Handihaler | 12 | $6,037 | $503 |
| Atorvastatin | 342 | $3,151 | $9 |
| Levothyroxine | 142 | $1,795 | $13 |
| Losartan | 132 | $1,530 | $12 |
| Olmesartan Medoxomil | 60 | $1,380 | $23 |
| Amlodipine Besylate | 176 | $1,070 | $6 |
| Rosuvastatin | 52 | $967 | $19 |
| Ezetimibe | 40 | $914 | $23 |
| Lisinopril | 97 | $806 | $8 |
| Metoprolol | 62 | $788 | $13 |
| Telmisartan | 13 | $734 | $56 |
| Metformin | 81 | $668 | $8 |
| Irbesartan | 11 | $645 | $59 |
| Simvastatin | 81 | $642 | $8 |
| Omeprazole | 29 | $482 | $17 |
| Pantoprazole | 23 | $431 | $19 |
| Valsartan-Hydrochlorothiazide | 13 | $361 | $28 |
| Benazepril | 22 | $356 | $16 |
| Escitalopram | 27 | $356 | $13 |
| Allopurinol | 35 | $329 | $9 |
| Metformin Hcl Er | 37 | $316 | $9 |
| Hydrochlorothiazide | 59 | $303 | $5 |
| Gabapentin | 18 | $293 | $16 |
| Tamsulosin | 13 | $278 | $21 |
| Alendronate | 35 | $270 | $8 |
| Albuterol Sulfate Hfa | 16 | $265 | $17 |
| Synthroid | 15 | $256 | $17 |
| Fluticasone Propionate | 13 | $231 | $18 |
| Citalopram Hbr | 11 | $186 | $17 |
| Potassium Chloride | 15 | $181 | $12 |
| Lansoprazole | 11 | $172 | $16 |
| Finasteride | 11 | $132 | $12 |
| Pravastatin | 15 | $130 | $9 |
| Losartan-Hydrochlorothiazide | 11 | $97 | $9 |
| Lorazepam | 19 | $90 | $5 |
| Montelukast | 21 | $73 | $3 |
| Atenolol | 14 | $57 | $4 |
| Tramadol | 20 | $55 | $3 |
| Triamcinolone Acetonide | 15 | $44 | $3 |
| Azithromycin | 12 | $44 | $4 |
| Terazosin | 14 | $4 | $0 |
Year by year
| 2024 | 2,491 | 298 | 1% (28) | None | $251,709 |
| 2023 | 3,317 | 342 | 2% (64) | 15% | $429,942 |
| 2022 | 3,312 | 355 | 2% (66) | 13% | $338,505 |
| 2021 | 3,722 | 388 | 2% (61) | 16% | $417,411 |
| 2020 | 3,072 | 347 | 2% (53) | None | $313,660 |
| 2019 | 2,447 | 296 | 2% (55) | 17% | $241,042 |
| 2018 | 1,914 | 249 | 4% (72) | 20% | $209,805 |
| 2017 | 922 | 187 | 6% (52) | None | $94,658 |
| 2016 | 367 | 107 | 11% (42) | None | $21,897 |
| 2015 | 185 | 46 | 0% (0) | None | $17,338 |
| 2014 | 83 | 16 | None | 17% | $4,592 |
| 2013 | 33 | None | None | None | $1,411 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 70 drugs
| Eliquis | 36 | $35,208 | $978 |
| Creon | 11 | $34,807 | $3,164 |
| Januvia | 27 | $34,219 | $1,267 |
| Jardiance | 16 | $29,018 | $1,814 |
| Prolia | 13 | $22,111 | $1,701 |
| Xarelto | 19 | $19,122 | $1,006 |
| Farxiga | 15 | $19,098 | $1,273 |
| Belsomra | 14 | $8,066 | $576 |
| Symbicort | 19 | $7,537 | $397 |
| Flovent Hfa | 13 | $5,952 | $458 |
| Breo Ellipta | 11 | $5,643 | $513 |
| Atorvastatin | 363 | $4,208 | $12 |
| Arnuity Ellipta | 12 | $2,751 | $229 |
| Levothyroxine | 188 | $2,687 | $14 |
| Diclofenac | 18 | $2,664 | $148 |
| Losartan | 128 | $2,353 | $18 |
| Amlodipine Besylate | 195 | $2,207 | $11 |
| Estradiol | 11 | $1,970 | $179 |
| Metoprolol | 88 | $1,846 | $21 |
| Galantamine Er | 12 | $1,664 | $139 |
| Pregabalin | 24 | $1,440 | $60 |
| Olmesartan Medoxomil | 57 | $1,340 | $24 |
| Simvastatin | 94 | $1,309 | $14 |
| Rosuvastatin | 64 | $1,306 | $20 |
| Oxcarbazepine | 12 | $1,232 | $103 |
| Lisinopril | 143 | $1,200 | $8 |
| Pantoprazole | 36 | $1,001 | $28 |
| Metformin Hcl Er | 53 | $967 | $18 |
| Metformin | 84 | $955 | $11 |
| Gabapentin | 30 | $913 | $30 |
| Ezetimibe | 37 | $832 | $22 |
| Potassium Chloride | 14 | $831 | $59 |
| Alendronate | 61 | $796 | $13 |
| Benazepril | 24 | $789 | $33 |
| Mirtazapine | 17 | $778 | $46 |
| Telmisartan | 15 | $760 | $51 |
| Fluoxetine | 12 | $651 | $54 |
| Montelukast | 23 | $593 | $26 |
| Escitalopram | 31 | $590 | $19 |
| Allopurinol | 40 | $561 | $14 |
| Valsartan | 14 | $541 | $39 |
| Tamsulosin | 20 | $497 | $25 |
| Omeprazole | 46 | $491 | $11 |
| Hydrochlorothiazide | 92 | $475 | $5 |
| Albuterol Sulfate Hfa | 13 | $417 | $32 |
| Valsartan-Hydrochlorothiazide | 17 | $407 | $24 |
| Finasteride | 27 | $400 | $15 |
| Trazodone | 37 | $367 | $10 |
| Paroxetine | 13 | $353 | $27 |
| Acetaminophen-Codeine | 12 | $348 | $29 |
| Famotidine | 24 | $324 | $14 |
| Quetiapine | 15 | $310 | $21 |
| Losartan-Hydrochlorothiazide | 14 | $271 | $19 |
| Fludrocortisone Acetate | 11 | $247 | $22 |
| Clopidogrel | 12 | $242 | $20 |
| Pravastatin | 24 | $238 | $10 |
| Metoprolol | 14 | $236 | $17 |
| Triamterene-Hydrochlorothiazid | 13 | $228 | $18 |
| Lorazepam | 31 | $223 | $7 |
| Glipizide | 17 | $192 | $11 |
| Terazosin | 15 | $191 | $13 |
| Citalopram Hbr | 18 | $190 | $11 |
| Naproxen | 11 | $182 | $17 |
| Paxlovid (Eua) | 17 | $175 | $10 |
| Atenolol | 27 | $174 | $6 |
| Tramadol | 20 | $171 | $9 |
| Furosemide | 20 | $164 | $8 |
| Carvedilol | 13 | $111 | $9 |
| Zolpidem | 18 | $98 | $5 |
| Azithromycin | 18 | $67 | $4 |
2022: 65 drugs
| Eliquis | 37 | $41,101 | $1,111 |
| Januvia | 26 | $30,195 | $1,161 |
| Jardiance | 15 | $24,504 | $1,634 |
| Xarelto | 18 | $17,607 | $978 |
| Wixela Inhub | 26 | $11,545 | $444 |
| Symbicort | 25 | $9,485 | $379 |
| Flovent Hfa | 14 | $6,438 | $460 |
| Breo Ellipta | 11 | $4,511 | $410 |
| Atorvastatin | 362 | $3,918 | $11 |
| Estradiol | 13 | $3,289 | $253 |
| Levothyroxine | 191 | $2,967 | $16 |
| Rosuvastatin | 73 | $1,888 | $26 |
| Losartan | 146 | $1,740 | $12 |
| Diclofenac | 23 | $1,712 | $74 |
| Metoprolol | 92 | $1,627 | $18 |
| Galantamine Er | 13 | $1,605 | $123 |
| Amlodipine Besylate | 165 | $1,365 | $8 |
| Olmesartan Medoxomil | 53 | $1,354 | $26 |
| Simvastatin | 110 | $1,294 | $12 |
| Ezetimibe | 26 | $1,211 | $47 |
| Lisinopril | 170 | $1,206 | $7 |
| Irbesartan | 18 | $1,140 | $63 |
| Pantoprazole | 60 | $1,094 | $18 |
| Metformin | 121 | $1,015 | $8 |
| Gabapentin | 43 | $981 | $23 |
| Omeprazole | 62 | $958 | $15 |
| Valsartan-Hydrochlorothiazide | 18 | $908 | $50 |
| Alendronate | 53 | $850 | $16 |
| Potassium Chloride | 15 | $822 | $55 |
| Pregabalin | 16 | $793 | $50 |
| Benazepril | 25 | $775 | $31 |
| Valsartan | 17 | $746 | $44 |
| Quetiapine | 13 | $668 | $51 |
| Escitalopram | 24 | $609 | $25 |
| Hydrochlorothiazide | 105 | $600 | $6 |
| Albuterol Sulfate Hfa | 11 | $544 | $49 |
| Mirtazapine | 15 | $508 | $34 |
| Metformin Hcl Er | 41 | $477 | $12 |
| Pravastatin | 28 | $455 | $16 |
| Allopurinol | 33 | $401 | $12 |
| Losartan-Hydrochlorothiazide | 19 | $385 | $20 |
| Montelukast | 22 | $356 | $16 |
| Famotidine | 26 | $351 | $14 |
| Trazodone | 47 | $338 | $7 |
| Fludrocortisone Acetate | 13 | $331 | $25 |
| Tamsulosin | 23 | $324 | $14 |
| Triamterene-Hydrochlorothiazid | 19 | $286 | $15 |
| Fluticasone Propionate | 18 | $265 | $15 |
| Fluoxetine | 11 | $250 | $23 |
| Metoprolol | 20 | $227 | $11 |
| Paroxetine | 17 | $213 | $13 |
| Lorazepam | 31 | $185 | $6 |
| Terazosin | 16 | $170 | $11 |
| Atenolol | 24 | $155 | $6 |
| Hydrocodone-Acetaminophen | 14 | $150 | $11 |
| Glipizide | 13 | $147 | $11 |
| Tramadol | 18 | $144 | $8 |
| Zolpidem | 13 | $137 | $11 |
| Finasteride | 14 | $133 | $10 |
| Methimazole | 13 | $126 | $10 |
| Citalopram Hbr | 20 | $122 | $6 |
| Clopidogrel | 11 | $120 | $11 |
| Lisinopril-Hydrochlorothiazide | 13 | $108 | $8 |
| Furosemide | 22 | $72 | $3 |
| Triamcinolone Acetonide | 11 | $34 | $3 |
2021: 72 drugs
| Eliquis | 63 | $47,887 | $760 |
| Januvia | 31 | $38,289 | $1,235 |
| Trulicity | 23 | $33,284 | $1,447 |
| Jardiance | 17 | $22,387 | $1,317 |
| Victoza 3-Pak | 11 | $11,384 | $1,035 |
| Symbicort | 24 | $10,715 | $446 |
| Xarelto | 11 | $9,169 | $834 |
| Incruse Ellipta | 12 | $7,522 | $627 |
| Spiriva | 12 | $6,047 | $504 |
| Wixela Inhub | 17 | $5,624 | $331 |
| Atorvastatin | 366 | $4,975 | $14 |
| Belsomra | 12 | $4,851 | $404 |
| Olmesartan Medoxomil | 52 | $4,131 | $79 |
| Levothyroxine | 191 | $3,696 | $19 |
| Rosuvastatin | 76 | $3,644 | $48 |
| Ezetimibe | 39 | $3,351 | $86 |
| Estradiol | 11 | $2,715 | $247 |
| Metoprolol | 89 | $2,374 | $27 |
| Pregabalin | 31 | $2,044 | $66 |
| Losartan | 142 | $1,669 | $12 |
| Valsartan | 19 | $1,643 | $86 |
| Lisinopril | 185 | $1,481 | $8 |
| Felodipine Er | 19 | $1,475 | $78 |
| Amlodipine Besylate | 195 | $1,447 | $7 |
| Potassium Chloride | 19 | $1,325 | $70 |
| Irbesartan | 21 | $1,319 | $63 |
| Metformin | 134 | $1,253 | $9 |
| Pantoprazole | 50 | $1,075 | $21 |
| Simvastatin | 99 | $938 | $9 |
| Omeprazole | 55 | $911 | $17 |
| Valsartan-Hydrochlorothiazide | 14 | $900 | $64 |
| Alendronate | 65 | $777 | $12 |
| Pravastatin | 32 | $728 | $23 |
| Albuterol Sulfate Hfa | 16 | $726 | $45 |
| Ventolin Hfa | 12 | $700 | $58 |
| Allopurinol | 37 | $688 | $19 |
| Hydrochlorothiazide | 99 | $688 | $7 |
| Fluticasone Propionate | 34 | $660 | $19 |
| Gabapentin | 43 | $610 | $14 |
| Tamsulosin | 27 | $596 | $22 |
| Diclofenac | 18 | $506 | $28 |
| Bupropion Xl | 15 | $494 | $33 |
| Escitalopram | 22 | $492 | $22 |
| Triamterene-Hydrochlorothiazid | 24 | $470 | $20 |
| Famotidine | 31 | $459 | $15 |
| Fluoxetine | 16 | $435 | $27 |
| Hydrocodone-Acetaminophen | 18 | $417 | $23 |
| Benazepril | 23 | $395 | $17 |
| Losartan-Hydrochlorothiazide | 15 | $390 | $26 |
| Montelukast | 23 | $386 | $17 |
| Terazosin | 26 | $378 | $15 |
| Trazodone | 28 | $369 | $13 |
| Metformin Hcl Er | 27 | $291 | $11 |
| Metoprolol | 20 | $284 | $14 |
| Ketoconazole | 11 | $279 | $25 |
| Sertraline | 18 | $259 | $14 |
| Lorazepam | 40 | $259 | $6 |
| Furosemide | 37 | $241 | $7 |
| Baclofen | 16 | $222 | $14 |
| Finasteride | 13 | $211 | $16 |
| Clopidogrel | 11 | $206 | $19 |
| Atenolol | 16 | $171 | $11 |
| Carvedilol | 20 | $171 | $9 |
| Triamcinolone Acetonide | 25 | $159 | $6 |
| Citalopram Hbr | 22 | $154 | $7 |
| Lisinopril-Hydrochlorothiazide | 20 | $148 | $7 |
| Tramadol | 17 | $133 | $8 |
| Paroxetine | 16 | $120 | $8 |
| Glipizide | 11 | $109 | $10 |
| Naproxen | 14 | $96 | $7 |
| Zolpidem | 17 | $72 | $4 |
| Alprazolam | 11 | $12 | $1 |
2020: 67 drugs
| Eliquis | 35 | $25,686 | $734 |
| Januvia | 27 | $23,638 | $875 |
| Xarelto | 17 | $14,468 | $851 |
| Victoza 3-Pak | 12 | $13,478 | $1,123 |
| Symbicort | 29 | $10,883 | $375 |
| Incruse Ellipta | 18 | $9,264 | $515 |
| Advair Diskus | 21 | $6,426 | $306 |
| Atorvastatin | 268 | $4,670 | $17 |
| Rosuvastatin | 62 | $3,988 | $64 |
| Flovent Hfa | 11 | $3,925 | $357 |
| Wixela Inhub | 12 | $3,701 | $308 |
| Levothyroxine | 135 | $3,338 | $25 |
| Duloxetine | 11 | $3,312 | $301 |
| Lantus Solostar | 12 | $3,037 | $253 |
| Pregabalin | 30 | $2,477 | $83 |
| Olmesartan Medoxomil | 30 | $2,221 | $74 |
| Ezetimibe | 21 | $1,939 | $92 |
| Mometasone Furoate | 19 | $1,665 | $88 |
| Metoprolol | 50 | $1,589 | $32 |
| Pantoprazole | 50 | $1,276 | $26 |
| Losartan | 120 | $1,268 | $11 |
| Amlodipine Besylate | 143 | $1,142 | $8 |
| Potassium Chloride | 23 | $1,061 | $46 |
| Losartan-Hydrochlorothiazide | 15 | $978 | $65 |
| Metformin | 131 | $882 | $7 |
| Pravastatin | 36 | $743 | $21 |
| Albuterol Sulfate Hfa | 17 | $708 | $42 |
| Lisinopril | 119 | $703 | $6 |
| Temazepam | 16 | $696 | $44 |
| Omeprazole | 38 | $658 | $17 |
| Fluoxetine | 11 | $597 | $54 |
| Hydrochlorothiazide | 88 | $592 | $7 |
| Simvastatin | 77 | $568 | $7 |
| Diclofenac | 24 | $567 | $24 |
| Gabapentin | 51 | $563 | $11 |
| Allopurinol | 25 | $557 | $22 |
| Tamsulosin | 31 | $466 | $15 |
| Bupropion Xl | 23 | $465 | $20 |
| Hydrocodone-Acetaminophen | 19 | $372 | $20 |
| Alendronate | 36 | $371 | $10 |
| Trazodone | 42 | $358 | $9 |
| Lorazepam | 53 | $329 | $6 |
| Montelukast | 14 | $318 | $23 |
| Famotidine | 22 | $316 | $14 |
| Furosemide | 32 | $307 | $10 |
| Benazepril | 24 | $306 | $13 |
| Triamcinolone Acetonide | 36 | $289 | $8 |
| Metoprolol | 27 | $241 | $9 |
| Triamterene-Hydrochlorothiazid | 16 | $230 | $14 |
| Terazosin | 11 | $227 | $21 |
| Finasteride | 15 | $219 | $15 |
| Fluticasone Propionate | 14 | $217 | $15 |
| Lisinopril-Hydrochlorothiazide | 19 | $213 | $11 |
| Verapamil Er | 11 | $199 | $18 |
| Clopidogrel | 12 | $199 | $17 |
| Escitalopram | 14 | $196 | $14 |
| Hydroxyzine | 11 | $193 | $18 |
| Naproxen | 15 | $145 | $10 |
| Prednisone | 15 | $117 | $8 |
| Sertraline | 11 | $111 | $10 |
| Zolpidem | 15 | $99 | $7 |
| Carvedilol | 15 | $93 | $6 |
| Paroxetine | 11 | $83 | $8 |
| Atenolol | 13 | $82 | $6 |
| Tramadol | 11 | $69 | $6 |
| Metformin Hcl Er | 15 | $62 | $4 |
| Alprazolam | 15 | $24 | $2 |
2019: 58 drugs
| Genvoya | 14 | $28,069 | $2,005 |
| Eliquis | 43 | $21,054 | $490 |
| Januvia | 23 | $20,786 | $904 |
| Atrovent Hfa | 23 | $11,828 | $514 |
| Xarelto | 16 | $7,286 | $455 |
| Incruse Ellipta | 14 | $4,716 | $337 |
| Rosuvastatin | 46 | $4,604 | $100 |
| Atorvastatin | 253 | $4,375 | $17 |
| Advair Diskus | 18 | $3,631 | $202 |
| Shingrix | 13 | $2,193 | $169 |
| Levothyroxine | 64 | $1,602 | $25 |
| Metoprolol | 48 | $1,050 | $22 |
| Flovent Hfa | 11 | $974 | $89 |
| Metformin | 118 | $956 | $8 |
| Losartan | 89 | $922 | $10 |
| Pantoprazole | 42 | $860 | $20 |
| Duloxetine | 13 | $825 | $63 |
| Amlodipine Besylate | 82 | $633 | $8 |
| Lisinopril | 76 | $553 | $7 |
| Escitalopram | 19 | $527 | $28 |
| Fluoxetine | 17 | $518 | $30 |
| Gabapentin | 37 | $474 | $13 |
| Pravastatin | 15 | $468 | $31 |
| Hydrocodone-Acetaminophen | 15 | $466 | $31 |
| Allopurinol | 25 | $453 | $18 |
| Omeprazole | 29 | $441 | $15 |
| Diltiazem 24hr Er (Cd) | 18 | $427 | $24 |
| Simvastatin | 35 | $371 | $11 |
| Losartan-Hydrochlorothiazide | 27 | $364 | $13 |
| Tamsulosin | 25 | $338 | $14 |
| Nifedipine Er | 12 | $335 | $28 |
| Felodipine Er | 13 | $323 | $25 |
| Hydrochlorothiazide | 54 | $308 | $6 |
| Potassium Chloride | 13 | $264 | $20 |
| Verapamil Er | 20 | $249 | $12 |
| Venlafaxine Hcl Er | 19 | $247 | $13 |
| Alendronate | 28 | $239 | $9 |
| Eszopiclone | 11 | $237 | $22 |
| Fluticasone Propionate | 17 | $230 | $14 |
| Atenolol | 15 | $224 | $15 |
| Trazodone | 31 | $222 | $7 |
| Furosemide | 15 | $187 | $12 |
| Mirtazapine | 15 | $185 | $12 |
| Metformin Hcl Er | 20 | $176 | $9 |
| Benazepril | 15 | $174 | $12 |
| Famotidine | 22 | $163 | $7 |
| Trueplus Pen Needle | 14 | $162 | $12 |
| Zolpidem | 16 | $158 | $10 |
| Lorazepam | 33 | $141 | $4 |
| Sertraline | 24 | $132 | $6 |
| Naproxen | 13 | $131 | $10 |
| Finasteride | 12 | $123 | $10 |
| Metoprolol | 14 | $123 | $9 |
| Triamterene-Hydrochlorothiazid | 11 | $123 | $11 |
| Triamcinolone Acetonide | 23 | $116 | $5 |
| Tramadol | 12 | $96 | $8 |
| Carvedilol | 13 | $76 | $6 |
| Lisinopril-Hydrochlorothiazide | 11 | $74 | $7 |
2018: 45 drugs
| Eliquis | 29 | $13,785 | $475 |
| Advair Diskus | 21 | $8,254 | $393 |
| Atrovent Hfa | 14 | $6,905 | $493 |
| Anoro Ellipta | 12 | $4,842 | $403 |
| Incruse Ellipta | 12 | $3,698 | $308 |
| Atorvastatin | 176 | $3,012 | $17 |
| Metoprolol | 40 | $1,706 | $43 |
| Levothyroxine | 62 | $1,380 | $22 |
| Rosuvastatin | 16 | $1,038 | $65 |
| Ventolin Hfa | 20 | $983 | $49 |
| Losartan | 65 | $686 | $11 |
| Metformin | 81 | $678 | $8 |
| Duloxetine | 15 | $660 | $44 |
| Donepezil | 11 | $631 | $57 |
| Lisinopril | 85 | $566 | $7 |
| Hydrocodone-Acetaminophen | 20 | $519 | $26 |
| Fenofibrate | 12 | $487 | $41 |
| Escitalopram | 11 | $453 | $41 |
| Omeprazole | 36 | $442 | $12 |
| Tamsulosin | 12 | $385 | $32 |
| Pantoprazole | 41 | $368 | $9 |
| Gabapentin | 39 | $368 | $9 |
| Fluticasone Propionate | 23 | $367 | $16 |
| Amlodipine Besylate | 68 | $322 | $5 |
| Alendronate | 34 | $298 | $9 |
| Hydrochlorothiazide | 37 | $297 | $8 |
| Allopurinol | 17 | $291 | $17 |
| Finasteride | 14 | $291 | $21 |
| Losartan-Hydrochlorothiazide | 17 | $211 | $12 |
| Nystop | 12 | $201 | $17 |
| Simvastatin | 21 | $190 | $9 |
| Metoprolol | 29 | $179 | $6 |
| Trueplus Pen Needle | 12 | $145 | $12 |
| Prednisone | 17 | $130 | $8 |
| Diltiazem 24hr Er (Cd) | 11 | $127 | $12 |
| Montelukast | 17 | $114 | $7 |
| Triamcinolone Acetonide | 18 | $113 | $6 |
| Azithromycin | 12 | $102 | $8 |
| Trazodone | 20 | $100 | $5 |
| Sertraline | 12 | $85 | $7 |
| Lorazepam | 26 | $75 | $3 |
| Furosemide | 15 | $73 | $5 |
| Acetaminophen-Codeine | 13 | $72 | $6 |
| Carvedilol | 12 | $64 | $5 |
| Tramadol | 14 | $58 | $4 |
2017: 22 drugs
| Propafenone Hcl Er | 13 | $3,753 | $289 |
| Advair Diskus | 18 | $2,910 | $162 |
| Famotidine | 16 | $799 | $50 |
| Atorvastatin | 59 | $768 | $13 |
| Donepezil | 19 | $606 | $32 |
| Levothyroxine | 26 | $354 | $14 |
| Hydrocodone-Acetaminophen | 20 | $329 | $16 |
| Metformin | 37 | $326 | $9 |
| Omeprazole | 25 | $296 | $12 |
| Amlodipine Besylate | 26 | $219 | $8 |
| Lisinopril | 42 | $209 | $5 |
| Alendronate | 27 | $195 | $7 |
| Simvastatin | 19 | $184 | $10 |
| Losartan | 28 | $172 | $6 |
| Fluticasone Propionate | 12 | $143 | $12 |
| Metoprolol | 20 | $120 | $6 |
| Trazodone | 15 | $104 | $7 |
| Escitalopram | 11 | $85 | $8 |
| Clopidogrel | 16 | $83 | $5 |
| Azithromycin | 15 | $74 | $5 |
| Hydrochlorothiazide | 24 | $58 | $2 |
| Tramadol | 14 | $45 | $3 |
2016: 6 drugs
| Atorvastatin | 25 | $323 | $13 |
| Donepezil | 11 | $161 | $15 |
| Lisinopril | 36 | $154 | $4 |
| Levothyroxine | 11 | $137 | $12 |
| Metformin | 18 | $90 | $5 |
| Amlodipine Besylate | 14 | $63 | $4 |
2015: 1 drug
| Simvastatin | 21 | $54 | $3 |
2014: 1 drug
| Lisinopril | 12 | $95 | $8 |
Money from drug and device companies
$159 in 2025
| 2025 | 3 | 6 | None | $159 |
| 2024 | 5 | 16 | None | $283 |
| 2023 | 7 | 12 | None | $281 |
| 2022 | 1 | 2 | None | $45 |
| 2020 | 7 | 15 | None | $319 |
| 2019 | 13 | 44 | None | $693 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Ubrelvy | $115 | 4 payments
|
| Novo Nordisk | None | $23 | 1 payment
|
| Amgen | Evenity | $21 | 1 payment
|
See all 6 published payments
| Abbvie | Meals · 2025-10-22 | Qulipta | $21 |
| Abbvie | Meals · 2025-09-03 | Qulipta | $30 |
| Novo Nordisk | Meals · 2025-06-12 | None | $23 |
| Abbvie | Meals · 2025-04-16 | Ubrelvy | $29 |
| Amgen | Meals · 2025-03-17 | Evenity | $21 |
| Abbvie | Meals · 2025-01-08 | Ubrelvy | $35 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $283
| ViiV Healthcare | Cabenuva | $169 | 11 payments
|
| Pfizer | Nurtec Odt | $37 | 2 payments
|
| Abbvie | Qulipta | $34 | 1 payment
|
| Novo Nordisk | None | $22 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $21 | 1 payment
|
2023: $281
| ViiV Healthcare | Dovato | $137 | 6 payments
|
| Theratechnologies | Egrifta | $37 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $29 | 1 payment
|
| Pfizer | Nurtec Odt | $26 | 1 payment
|
| Amgen | Evenity | $19 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
| Janssen Biotech | Symtuza | $14 | 1 payment
|
2022: $45
| Novo Nordisk | Rybelsus | $45 | 2 payments
|
2020: $319
| ViiV Healthcare | Dovato | $170 | 8 payments
|
| GlaxoSmithKline | Anoro Ellipta | $48 | 2 payments
|
| Sanofi Pasteur | Fluzone Quadrivalent | $27 | 1 payment
|
| Allergan | Ubrelvy | $23 | 1 payment
|
| Gilead Sciences | None | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $17 | 1 payment
|
| Merck Sharp & Dohme | Pneumovax 23 | $16 | 1 payment
|
2019: $693
| ViiV Healthcare | Dovato | $331 | 25 payments
|
| Gilead Sciences | None | $71 | 3 payments
|
| Astellas Pharma US | Myrbetriq | $44 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $40 | 2 payments
|
| Merck Sharp & Dohme | Isentress | $36 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $31 | 2 payments
|
| Janssen Biotech | Symtuza | $27 | 2 payments
|
| Regeneron Healthcare Solutions | Praluent | $24 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Symbicort | $21 | 1 payment
|
| Circassia Pharmaceuticals | Tudorza Pressair | $20 | 1 payment
|
| Allergan | Vraylar | $20 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $14 | 1 payment
|
| Novo Nordisk | Tresiba | $13 | 1 payment
|
Professional record
- NPI
- 1699112169
- Licence
- CA A134695California A134695: Current · expires 2028-03-31
- Group
- Dignity Health · Mercy Doctors Medical Group, Inc
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 1 Shrader St Ste 640, San Francisco, CA, 94117
- NPI first listed
- 2013-05-23
- NPI last updated
- 2015-09-14
This is when the NPI record was last certified, not a medical board exam.